Ligand Pharmaceuticals Inc (LGND)
Income Tax Expense
$15.80M
Quarterly · Period ending: · USD
LGND Income Tax Expense
Latest reported$15.80Mperiod ending
Latest reported$15.80Mperiod ending
LGND Quarterly Income Tax ($0.00 → $15.80M)
Quarterly income tax expense
High-resolution chart · PNG
LGND income tax expense history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Income Tax Expense (USD) |
|---|---|
| 15,796,000 | |
| -10,914,000 | |
| 11,996,000 | |
| 23,864,000 | |
| 6,376,000 | |
| -7,729,000 | |
| -8,112,000 | |
| 833,000 | |
| -13,479,000 | |
| 27,308,000 | |
| -1,091,000 | |
| -1,871,000 | |
| 881,000 | |
| 11,922,000 | |
| 45,273,000 | |
| 2,709,000 | |
| -3,938,000 | |
| 3,785,000 | |
| -1,610,000 | |
| 1,536,000 | |
| 2,576,000 | |
| -12,342,000 | |
| -2,391,000 | |
| -4,911,000 | |
| 6,033,000 | |
| -6,284,000 | |
| -810,000 | |
| -4,620,000 | |
| -3,609,000 | |
| 176,376,000 | |
| -14,307,000 | |
| 11,864,000 | |
| 22,419,000 | |
| 10,033,000 | |
| 37,675,000 | |
| 3,645,000 | |
| 2,242,000 | |
| 1,114,000 | |
| 10,355,000 | |
| 160,000 | |
| -3,881,000 | |
| 3,694,000 | |
| -515,000 | |
| -217,255,000 | |
| 265,000 | |
| 15,000 | |
| 279,000 | |
| 124,000 | |
| -47,000 | |
| 53,000 | |
| 139,000 | |
| 60,000 | |
| 110,000 | |
| 66,000 | |
| -1,636,000 | |
| 142,000 | |
| 338,000 | |
| -35,000 | |
| 495,000 | |
| 22,000 | |
| 141,000 | |
| -13,778,000 | |
| -3,935,000 | |
| 419,000 | |
| 625,000 | |
| 274,000 | |
| -1,535,000 | |
| 0 | |
| 0 | |
| 0 | |
| -234,000 | |
| 2,990,000 | |
| -1,030,000 | |
| -1,781,000 | |
| -2,918,000 | |
| -2,360,000 | |
| -4,225,000 | |
| -9,194,000 | |
| -36,124,000 | |
| -828,000 | |
| 18,000 | |
| 17,000 | |
| 5,000 | |
| 17,000 | |
| 17,000 | |
| 20,000 | |
| -56,000 | |
| 2,904,000 | |
| 2,951,000 | |
| 2,873,000 | |
| -43,404,000 | |
| 0 | |
| 0 | |
| 0 | |
| -25,868,000 | |
| 0 | |
| 2,771,000 | |
| 4,228,000 | |
| 10,508,000 | |
| 3,185,000 |